[{"Assets_0_Q2_USD":"1258544000.0","CIK":"1737287","CommonStockSharesConverted_0_Q2_shares":"139233450.0","CommonStockSharesOutstanding_0_Q2_shares":"139233450.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.53","EarningsPerShareBasic_2_Q2_USD":"-1.03","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-67530000.0","NetIncomeLossConverted_1_Q2_USD":"-60974000.0","NetIncomeLossConverted_2_Q2_USD":"-115454000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"1163419000.0","Ticker":"ALLO","filed":"20200805","footnote":null,"form":"10-Q","fp":"Q2","fy":"2020.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20200630","qtrs":"1","uom":"USD"}]